News and Announcements
Universal Biosensors Announces Retirement of CEO Paul Wright
- Published February 19, 2016 10:51AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19th February 2016, ASX Announcement
Mr. Wright announced today his decision to retire as Chief Executive Officer of Universal Biosensors, Inc. (ASX:UBI) and to resign from the Company’s Board of Directors, with effect from 10 March 2016.
Mr. Wright noted that with two commercial products on the market and the release of solid FY2015 results, Universal Biosensors is well placed to consolidate its position as an innovative and dynamic point-of-care diagnostics company. He has been instrumental in fostering strong relationships with UBI’s commercial partners, Siemens & LifeScan (Johnson & Johnson), and in identifying new opportunities for UBI’s technology.
After five years with Universal Biosensors, Mr. Wright has indicated his desire to pursue new opportunities.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
